Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant

To assess anatomical and functional outcomes after switching from dexamethasone implant (DEXi) to fluocinolone acetonide implant (FAci) in 113 diabetic macular edema eyes, a multicentric retrospective observational study was conducted. Seventy-five eyes (73.5%) were switched 1–8 weeks after their la...

Descripción completa

Detalles Bibliográficos
Autores principales: Baillif, Stéphanie, Staccini, Pascal, Weber, Michel, Delyfer, Marie-Noëlle, Le Mer, Yannick, Gualino, Vincent, Collot, Laurence, Merite, Pierre-Yves, Creuzot-Garcher, Catherine, Kodjikian, Laurent, Massin, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693281/
https://www.ncbi.nlm.nih.gov/pubmed/36365209
http://dx.doi.org/10.3390/pharmaceutics14112391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693281/
https://www.ncbi.nlm.nih.gov/pubmed/36365209
http://dx.doi.org/10.3390/pharmaceutics14112391

Ejemplares similares